Page last updated: 2024-11-05

tosufloxacin and Fever

tosufloxacin has been researched along with Fever in 3 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shinohara, A1
Yoshiki, Y1
Masamoto, Y1
Hangaishi, A1
Nannya, Y1
Kurokawa, M1
Haeusler, GM1
Slavin, MA1
Tsuji, Y1
Okamura, K1
Miyake, K1
Ito, H1
Kinukawa, T1
Otani, T1
Narushima, M1
Kanai, S1
Takagi, Y1
Murase, T1

Trials

1 trial available for tosufloxacin and Fever

ArticleYear
[Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:12

    Topics: Administration, Oral; Aged; Anti-Infective Agents; Cefotiam; Fever; Fluoroquinolones; Humans; Inject

1993

Other Studies

2 other studies available for tosufloxacin and Fever

ArticleYear
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquin

2013
Fluoroquinolone prophylaxis: worth the cost?
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans

2013